13F

ESTA ESTABLISHMENT LABS HOLDINGS INC.

2026Q1 · CUSIP G31249108 · Sector: Healthcare & Biotech

Neutral · No signal
Holders
173
Δ holders QoQ
0
Breadth percentile
Top 62%
Whale holders
82
Δ whales
+8
Inst. holding value
$1.5B
New positions
32
Closed positions
32
Price momentum (1Q)
Put / Call
4/8

Breadth history (34 quarters)

2018Q4: Δ-9 · h=26 2019Q1: Δ+0 · h=26 2019Q2: Δ+3 · h=29 2019Q3: Δ+4 · h=33 2019Q4: Δ+2 · h=35 2020Q1: Δ+9 · h=44 2020Q2: Δ-1 · h=43 2020Q3: Δ+0 · h=43 2020Q4: Δ+8 · h=51 2021Q1: Δ+16 · h=67 2021Q2: Δ+29 · h=96 2021Q3: Δ+0 · h=96 2021Q4: Δ+4 · h=100 2022Q1: Δ+6 · h=106 2022Q2: Δ-8 · h=98 2022Q3: Δ-3 · h=95 2022Q4: Δ+10 · h=105 2023Q1: Δ+7 · h=112 2023Q2: Δ-3 · h=109 2023Q3: Δ-3 · h=106 2023Q4: Δ-9 · h=97 2024Q1: Δ+21 · h=118 2024Q2: Δ+5 · h=123 2024Q3: Δ+6 · h=129 2024Q4: Δ-5 · h=124 2025Q1: Δ+14 · h=138 2025Q2: Δ+0 · h=138 2025Q3: Δ+11 · h=149 2025Q4: Δ+24 · h=173 2026Q1: Δ+0 · h=173 2018Q4: holders=26 2019Q1: holders=26 2019Q2: holders=29 2019Q3: holders=33 2019Q4: holders=35 2020Q1: holders=44 2020Q2: holders=43 2020Q3: holders=43 2020Q4: holders=51 2021Q1: holders=67 2021Q2: holders=96 2021Q3: holders=96 2021Q4: holders=100 2022Q1: holders=106 2022Q2: holders=98 2022Q3: holders=95 2022Q4: holders=105 2023Q1: holders=112 2023Q2: holders=109 2023Q3: holders=106 2023Q4: holders=97 2024Q1: holders=118 2024Q2: holders=123 2024Q3: holders=129 2024Q4: holders=124 2025Q1: holders=138 2025Q2: holders=138 2025Q3: holders=149 2025Q4: holders=173 2026Q1: holders=173 -29 -14.5 +0 +14.5 +29 23103182 18Q419Q320Q221Q121Q422Q323Q224Q124Q425Q326Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 4 lit events

Period Percentile Next-1Q return Next-2Q return
2025Q1 Top 18%
2024Q1 Top 14%
2021Q2 Top 8%
2020Q1 Top 10%

Options Sentiment

Put holders
4
QoQ: -4
Call holders
8
QoQ: +3

See methodology →

Fundamentals

PE (TTM)
EPS (TTM)
$-1.47
EPS YoY
Revenue (TTM)
$0.2B
Revenue YoY
+34.9%
Quarterly Revenue & EPS (4Y)
2022-06-30: $41M 2022-09-30: $38M 2022-12-31: $44M 2023-03-31: $47M 2023-06-30: $49M 2023-09-30: $39M 2023-12-31: $32M 2024-03-31: $37M 2024-06-30: $44M 2024-09-30: $40M 2024-12-31: $45M 2025-03-31: $41M 2025-06-30: $51M 2025-09-30: $54M 2025-12-31: $65M 2026-03-31: $60M 2022-06-30: EPS -1.52 2022-09-30: EPS -0.76 2022-12-31: EPS -0.56 2023-03-31: EPS -0.48 2023-06-30: EPS -0.65 2023-09-30: EPS -1.12 2023-12-31: EPS -0.82 2024-03-31: EPS -0.58 2024-06-30: EPS -0.62 2024-09-30: EPS -0.59 2024-12-31: EPS -1.21 2025-03-31: EPS -0.70 2025-06-30: EPS -0.57 2025-09-30: EPS -0.38 2025-12-31: EPS -0.07 2026-03-31: EPS -0.45 0M 32M 65M $M -1.67 -0.84 0.00 20222023202420252026 Revenue EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

As of 2026-03-31 · SEC filings (XBRL)